Loading...
SAHA-induced loss of the tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model
Thyroid cancer is on the rise. Novel approaches are needed to improve the outcome of patients with recurrent and advanced metastatic thyroid cancers. FDA approval of suberoylanilide hydroxamic acid (SAHA; vorinostat), an inhibitor of histone deacetylase, for the treatment of hematologic malignancies...
Saved in:
| Published in: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959547/ https://ncbi.nlm.nih.gov/pubmed/27267120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-16-0103 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|